Abstract
Background Mechanical thrombectomy (MT) is established as standard care for acute ischemic stroke (AIS) due to large vessel occlusion, but its role in distal medium vessel occlusions (DMVOs) remains uncertain. We conducted a systematic review and meta-analysis to evaluate the efficacy and safety of MT vs best medical management (BMM) in patients with DMVO-related AIS.
Methods A systematic search of PubMed, Embase, Scopus, and the Cochrane Library was conducted through February 2025 to identify randomized controlled trials (RCTs) comparing MT to BMM in patients with DMVO. The primary outcome was functional independence at 90 days (modified Rankin Scale [mRS] 0–2). Secondary outcomes included excellent outcome (mRS 0–1), symptomatic intracerebral haemorrhage (sICH), all-cause mortality, and serious adverse events. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a random-effects model and heterogeneity was assessed with the I2 statistic.
Results Three RCTs involving 1,222 patients were included; 601 received MT and 623 received BMM. MT was not associated with improved functional independence at 90 days (OR, 0.81; 95% CI, 0.49–1.32). The risk of sICH was higher in the MT group (OR, 2.33; 95% CI, 1.31– 4.13), while mortality rates were similar (OR, 1.33; 95% CI, 0.90–1.98). In a subgroup of 466 patients with M2 occlusions, MT showed no significant benefit over BMM (OR, 0.93; 95% CI, 0.72–1.19).
Conclusions MT did not improve functional outcomes in patients with DMVO, including those with M2 occlusions, and was associated with a higher risk of sICH. Further trials are warranted to refine patient selection and procedural approaches in this population.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
PROSPERO REGISTRATION NUMBER - CRD420250651779
Funding Statement
No external funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable - study is based on published aggregate data only.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Available on request
Abbreviations
- AIS
- acute ischemic stroke
- BMM
- best medical management
- CI
- confidence interval
- DMVO
- distal medium vessel occlusion
- EVT
- endovascular thrombectomy
- mRS
- modified Rankin Scale
- NIHSS
- National Institutes of Health Stroke Scale
- sICH
- symptomatic intracranial haemorrhage
- TICI
- Thrombolysis in Cerebral Infarction.
